Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tyler Van Buren's Stock Ratings
TD Cowen Analyst
Tyler Van Buren is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/06/2025
Overall Average Return
-4.81%
Smart Score
Overall Average Return Percentile
29th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 01/07/2025 | CGON | Buy Now | CG Oncology | $28.18 | — | Tyler Van Buren46% | — | Initiates | → Buy | Get Alert |
| 12/12/2024 | KROS | Buy Now | Keros Therapeutics | $14.53 | — | Tyler Van Buren46% | — | Downgrade | Buy → Hold | Get Alert |
| 11/13/2024 | BHVN | Buy Now | Biohaven | $22.62 | 231.56% | Tyler Van Buren46% | $55 → $75 | Maintains | Buy | Get Alert |
| 10/08/2024 | BCAX | Buy Now | Bicara Therapeutics | $14.00 | — | Tyler Van Buren46% | — | Initiates | → Buy | Get Alert |
| 09/16/2024 | ORKA | Buy Now | Oruka Therapeutics | $9.98 | — | Tyler Van Buren46% | — | Initiates | → Buy | Get Alert |
| 09/13/2024 | MRNA | Buy Now | Moderna | $27.54 | 117.86% | Tyler Van Buren46% | $70 → $60 | Maintains | Hold | Get Alert |
| 08/13/2024 | ARTV | Buy Now | Artiva Biotherapeutics | $2.22 | — | Tyler Van Buren46% | — | Initiates | → Buy | Get Alert |
| 08/06/2024 | RNAC | Buy Now | Cartesian Therapeutics | $12.50 | — | Tyler Van Buren46% | — | Initiates | → Buy | Get Alert |
| 07/23/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $603.71 | 98.77% | Tyler Van Buren46% | $1030 → $1200 | Maintains | Buy | Get Alert |
| 06/24/2024 | TECX | Buy Now | Tectonic Therapeutic | $21.65 | — | Tyler Van Buren46% | — | Initiates | → Buy | Get Alert |
| 05/15/2024 | NAMS | Buy Now | NewAmsterdam Pharma | $19.70 | — | Tyler Van Buren46% | — | Initiates | → Buy | Get Alert |
| 04/26/2024 | GILD | Buy Now | Gilead Sciences | $102.47 | -17.05% | Tyler Van Buren46% | $90 → $85 | Maintains | Buy | Get Alert |
| 04/24/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $603.71 | 70.61% | Tyler Van Buren46% | $1020 → $1030 | Maintains | Buy | Get Alert |
| 03/01/2024 | BHVN | Buy Now | Biohaven | $22.62 | 143.15% | Tyler Van Buren46% | $35 → $55 | Maintains | Outperform | Get Alert |
| 12/11/2023 | CRSP | Buy Now | CRISPR Therapeutics | $37.50 | -20% | Tyler Van Buren46% | → $30 | Downgrade | Market Perform → Underperform | Get Alert |
| 12/06/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $603.71 | 65.64% | Tyler Van Buren46% | $900 → $1000 | Maintains | Outperform | Get Alert |
| 12/05/2023 | CRGX | Buy Now | Cargo Therapeutics | $4.23 | — | Tyler Van Buren46% | — | Initiates | → Outperform | Get Alert |
| 11/29/2023 | SYRE | Buy Now | Spyre Therapeutics | $14.09 | — | Tyler Van Buren46% | — | Initiates | → Outperform | Get Alert |
| 10/30/2023 | ACLX | Buy Now | Arcellx | $64.64 | — | Tyler Van Buren46% | — | Initiates | → Outperform | Get Alert |
| 08/08/2023 | APGE | Buy Now | Apogee Therapeutics | $39.39 | — | Tyler Van Buren46% | — | Initiates | → Outperform | Get Alert |
| 08/04/2023 | MRNA | Buy Now | Moderna | $27.54 | 353.89% | Tyler Van Buren46% | $145 → $125 | Downgrade | Outperform → Market Perform | Get Alert |
| 07/24/2023 | MRNA | Buy Now | Moderna | $27.54 | 499.13% | Tyler Van Buren46% | $175 → $165 | Maintains | Outperform | Get Alert |
| 07/06/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | Tyler Van Buren46% | → $140 | Initiates | → Outperform | Get Alert |
| 05/30/2023 | SLRN | Buy Now | Acelyrin | $2.41 | — | Tyler Van Buren46% | — | Initiates | → Outperform | Get Alert |
| 05/22/2023 | TVTX | Buy Now | Travere Therapeutics | $21.20 | 41.51% | Tyler Van Buren46% | → $30 | Initiates | → Outperform | Get Alert |
| 04/20/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $603.71 | 46.59% | Tyler Van Buren46% | $875 → $885 | Maintains | Outperform | Get Alert |
| 03/13/2023 | MRNA | Buy Now | Moderna | $27.54 | 553.59% | Tyler Van Buren46% | $150 → $180 | Upgrade | Market Perform → Outperform | Get Alert |
| 02/14/2023 | KROS | Buy Now | Keros Therapeutics | $14.53 | — | Tyler Van Buren46% | — | Initiates | → Outperform | Get Alert |
| 02/06/2023 | BBIO | Buy Now | BridgeBio Pharma | $38.22 | — | Tyler Van Buren46% | — | Initiates | → Outperform | Get Alert |
| 01/30/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $603.71 | 44.94% | Tyler Van Buren46% | $775 → $875 | Upgrade | Market Perform → Outperform | Get Alert |
| 01/25/2023 | MRNA | Buy Now | Moderna | $27.54 | 444.66% | Tyler Van Buren46% | $130 → $150 | Maintains | Market Perform | Get Alert |
| 01/25/2023 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Tyler Van Buren46% | $25 → $30 | Maintains | Outperform | Get Alert |
| 01/06/2023 | FATE | Buy Now | Fate Therapeutics | $1.24 | — | Tyler Van Buren46% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 11/08/2022 | GILD | Buy Now | Gilead Sciences | $102.47 | -12.17% | Tyler Van Buren46% | $80 → $90 | Maintains | Outperform | Get Alert |
| 10/20/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $603.71 | 24.23% | Tyler Van Buren46% | $655 → $750 | Maintains | Market Perform | Get Alert |
| 08/29/2022 | DCPH | Buy Now | Deciphera Pharmaceuticals | — | — | Tyler Van Buren46% | → $25 | Initiates | → Outperform | Get Alert |
| 08/08/2022 | IMCR | Buy Now | Immunocore Hldgs | $30.68 | 128.16% | Tyler Van Buren46% | → $70 | Initiates | → Outperform | Get Alert |
| 07/20/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $603.71 | 6.84% | Tyler Van Buren46% | $635 → $645 | Maintains | Market Perform | Get Alert |
| 07/12/2022 | ZNTL | Buy Now | Zentalis Pharma | $1.36 | — | Tyler Van Buren46% | — | Initiates | → Outperform | Get Alert |
| 06/06/2022 | TPTX | Buy Now | Turning Point | — | — | Tyler Van Buren46% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 12/07/2021 | FATE | Buy Now | Fate Therapeutics | $1.24 | — | Tyler Van Buren46% | — | Initiates | → Outperform | Get Alert |
| 12/07/2021 | MRNA | Buy Now | Moderna | $27.54 | 807.77% | Tyler Van Buren46% | → $250 | Initiates | → Market Perform | Get Alert |
| 12/07/2021 | CRSP | Buy Now | CRISPR Therapeutics | $37.50 | — | Tyler Van Buren46% | — | Initiates | → Market Perform | Get Alert |
| 12/07/2021 | TPTX | Buy Now | Turning Point | — | — | Tyler Van Buren46% | — | Initiates | → Outperform | Get Alert |
| 12/07/2021 | ARVN | Buy Now | Arvinas | $7.54 | — | Tyler Van Buren46% | — | Initiates | → Outperform | Get Alert |
| 10/11/2021 | TYRA | Buy Now | Tyra Biosciences | $10.50 | — | Tyler Van Buren46% | — | Initiates | → Outperform | Get Alert |
| 03/04/2021 | EPIX | Buy Now | ESSA Pharma | $1.83 | 2632.24% | Tyler Van Buren46% | → $50 | Initiates | → Overweight | Get Alert |
| 02/10/2021 | CBIO | Buy Now | Catalyst Biosciences | — | — | Tyler Van Buren46% | → $15 | Initiates | → Overweight | Get Alert |
| 02/02/2021 | GRCL | Buy Now | Gracell Biotechnologies | — | — | Tyler Van Buren46% | → $40 | Initiates | → Overweight | Get Alert |
| 11/10/2020 | ALGS | Buy Now | Aligos Therapeutics | $5.48 | 538.69% | Tyler Van Buren46% | → $35 | Initiates | → Overweight | Get Alert |
| 11/06/2020 | BGNE | Buy Now | BeiGene | — | — | Tyler Van Buren46% | → $185 | Downgrade | Neutral → Underweight | Get Alert |
| 11/05/2020 | MRTX | Buy Now | Mirati Therapeutics | — | — | Tyler Van Buren46% | $210 → $260 | Maintains | Overweight | Get Alert |
| 10/29/2020 | GILD | Buy Now | Gilead Sciences | $102.47 | -18.02% | Tyler Van Buren46% | $95 → $84 | Maintains | Overweight | Get Alert |
| 10/26/2020 | MRTX | Buy Now | Mirati Therapeutics | — | — | Tyler Van Buren46% | $170 → $210 | Maintains | Overweight | Get Alert |
| 09/21/2020 | MRTX | Buy Now | Mirati Therapeutics | — | — | Tyler Van Buren46% | $145 → $170 | Maintains | Overweight | Get Alert |
| 08/19/2020 | GILD | Buy Now | Gilead Sciences | $102.47 | -19% | Tyler Van Buren46% | $85 → $83 | Maintains | Overweight | Get Alert |
| 08/18/2020 | INZY | Buy Now | Inozyme Pharma | $1.46 | 2639.73% | Tyler Van Buren46% | → $40 | Initiates | → Overweight | Get Alert |
| 08/18/2020 | NRIX | Buy Now | Nurix Therapeutics | $10.94 | 265.63% | Tyler Van Buren46% | → $40 | Initiates | → Overweight | Get Alert |
| 08/13/2020 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | Tyler Van Buren46% | $28 → $30 | Maintains | Overweight | Get Alert |
| 08/12/2020 | TCRR | Buy Now | TCR2 Therapeutics | — | — | Tyler Van Buren46% | → $35 | Initiates | → Overweight | Get Alert |
| 08/10/2020 | TBPH | Buy Now | Theravance Biopharma | $10.24 | 192.97% | Tyler Van Buren46% | $35 → $30 | Maintains | Overweight | Get Alert |
| 08/04/2020 | PSTX | Buy Now | Poseida Therapeutics | — | — | Tyler Van Buren46% | → $30 | Initiates | → Overweight | Get Alert |
| 07/21/2020 | AKUS | Buy Now | Akouos | — | — | Tyler Van Buren46% | → $40 | Initiates | → Overweight | Get Alert |
| 06/29/2020 | LPTX | Buy Now | Leap Therapeutics | $0.38 | 1500% | Tyler Van Buren46% | → $6 | Initiates | → Overweight | Get Alert |
| 06/29/2020 | PLRX | Buy Now | Pliant Therapeutics | $1.63 | 2967.48% | Tyler Van Buren46% | → $50 | Initiates | → Overweight | Get Alert |
| 05/22/2020 | HARP | Buy Now | Harpoon Therapeutics | — | — | Tyler Van Buren46% | → $35 | Initiates | → Overweight | Get Alert |
| 04/22/2020 | GOSS | Buy Now | Gossamer Bio | $1.20 | 2400% | Tyler Van Buren46% | → $30 | Initiates | → Overweight | Get Alert |
| 03/20/2020 | GILD | Buy Now | Gilead Sciences | $102.47 | — | Tyler Van Buren46% | — | Upgrade | Neutral → Overweight | Get Alert |
| 02/25/2020 | TBPH | Buy Now | Theravance Biopharma | $10.24 | 241.8% | Tyler Van Buren46% | $40 → $35 | Maintains | Overweight | Get Alert |
| 01/13/2020 | ADVM | Buy Now | Adverum Biotechnologies | $3.59 | 457.1% | Tyler Van Buren46% | $14 → $20 | Reiterates | → Overweight | Get Alert |
| 01/10/2020 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | Tyler Van Buren46% | → $20 | Initiates | → Overweight | Get Alert |
| 12/16/2019 | BGNE | Buy Now | BeiGene | — | — | Tyler Van Buren46% | — | Downgrade | Overweight → Neutral | Get Alert |
| 02/15/2019 | MRTX | Buy Now | Mirati Therapeutics | — | — | Tyler Van Buren46% | — | Initiates | → Overweight | Get Alert |
| 04/13/2018 | BGNE | Buy Now | BeiGene | — | — | Tyler Van Buren46% | → $200 | Initiates | → Overweight | Get Alert |
| 11/02/2017 | OMER | Buy Now | Omeros | $6.93 | — | Tyler Van Buren46% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 09/26/2017 | ALDR | Buy Now | Alder BioPharmaceuticals | — | — | Tyler Van Buren46% | → $20 | Initiates | → Outperform | Get Alert |
| 08/04/2017 | TEVA | Buy Now | Teva Pharmaceutical Indus | $16.56 | — | Tyler Van Buren46% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 04/05/2017 | NEOS | Buy Now | Neos Therapeutics | — | — | Tyler Van Buren46% | → $20 | Initiates | → Outperform | Get Alert |
| 02/24/2017 | AERI | Buy Now | Aerie Pharmaceuticals | — | — | Tyler Van Buren46% | → $70 | Initiates | → Outperform | Get Alert |
| 11/03/2016 | TBPH | Buy Now | Theravance Biopharma | $10.24 | — | Tyler Van Buren46% | — | Initiates | → Overweight | Get Alert |
| 09/17/2015 | MRTX | Buy Now | Mirati Therapeutics | — | — | Tyler Van Buren46% | $50 → $45 | Downgrade | Overweight → Neutral | Get Alert |
| 08/25/2014 | AAVL | Buy Now | Avalanche Biotechnologies, Inc. | — | — | Tyler Van Buren46% | → $39 | Initiates | → Overweight | Get Alert |
